SPRUCE BIOSCIENCES INC
For the period ended Dec 31, 2023. Filed Mar 18, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 18, 2024
SPRB$49.34+6.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets
(in thousands, except share and per share amounts)
| December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $96,339 | $24,487 |
| Short-term investments | — | 54,590 |
| Prepaid expenses | 3,876 | 3,320 |
| Other current assets | 1,968 | 1,211 |
| Total current assets | 102,183 | 83,608 |
| Right-of-use assets | 1,181 | 1,400 |
| Other assets | 582 | 640 |
| Total assets | $103,946 | $85,648 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $3,332 | $1,426 |
| Accrued expenses and other current liabilities | 14,600 | 9,399 |
| Term loan, current portion | 1,622 | 1,622 |
| Deferred revenue | 4,911 | — |
| Total current liabilities | 24,465 | 12,447 |
| Lease liabilities, net of current portion | 1,019 | 1,261 |
| Term loan, net of current portion | 1,717 | 3,293 |
| Other liabilities | 236 | 161 |
| Total liabilities | 27,437 | 17,162 |
| Commitments and contingencies (Note 7) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued or outstanding as of December 31, 2023 and 2022 | — | — |
| Common stock, $0.0001 par value; 200,000,000 shares authorized as of December 31, 2023 and 2022; 41,029,832 and 23,601,004 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 4 | 3 |
| Additional paid-in capital | 273,737 | 218,354 |
| Accumulated other comprehensive loss | — | (558) |
| Accumulated deficit | (197,232) | (149,313) |
| Total stockholders’ equity | 76,509 | 68,486 |
| Total liabilities and stockholders’ equity | $103,946 | $85,648 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.